Evidence map›Paper›PMID 39527101›Full record

ArticleCancer communications (London, England)2025

Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes.

Yong Peng, Jason Karpus, Jyoti D Patel, Everett E Vokes, Marina Chiara Garassino, Kirsteen Lugtu, Zhou Zhang, Wei Zhang, Mengjie Chen, Chuan He and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yong PengDepartment of Chemistry, The University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-3405-8836
Jason KarpusDepartment of Chemistry, The University of Chicago, Chicago, Illinois, USA.
Jyoti D PatelDivision of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois, USA.
Everett E VokesSection of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Marina Chiara GarassinoSection of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Kirsteen LugtuSection of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Zhou ZhangDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-9639-052X
Wei ZhangDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Mengjie ChenSection of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Chuan HeDepartment of Chemistry, The University of Chicago, Chicago, Illinois, USA.
Christine M BestvinaSection of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois, USA.

Funding

Develop new bioinformatics infrastructures and computational tools for epitranscriptomics dataR01HG012927 · NHGRI · UNIVERSITY OF CHICAGO · PI Mengjie Chen · 2023 to 2026
$1.6M
NHGRI NIH HHS R01 HG012927
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39527101
PMCPMC11758164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.